Oral Drug Delivery Solutions

1. Battelle uLAB 3/21/2024

   This comprehensive suite of services encompasses the entire spectrum of user research, starting from the conceptualization of study designs to meticulous data analysis and comprehensive reporting.

2. Pharmaceutical Development 4/24/2023

   Developing an optimized formulation tailored to your API nanoparticles is critical to unlocking their full potential.

3. Controlled Expansion Of Supercritical Solutions (CESS®) Technology 4/24/2023

   Nanoform’s award-winning Controlled Expansion of Supercritical Solutions (CESS®) technology is a bottom-up nanoparticle engineering approach that enables the creation of API nanoparticles and can unlock the full therapeutic potential of small molecule drugs.

4. Global Experts In Nanotechnology And Drug Particle Engineering 3/9/2023

   Discover the nanoparticle engineering, formulation and GMP manufacturing services that can drive forward your market success and unlock the power of “small."

5. End-To-End Drug Development, Analytical Testing, & Fill/Finish 2/15/2023

   August Bioservices is a US-based, quality-driven CDMO that offers end-to-end drug development, analytical testing, and fill/finish manufacturing services to clients of all sizes and stages, from pre-clinical to commercial.

6. Modified-Release Formulation Strategies 7/26/2022

   Learn what oral modified-release (MR) dosage forms can offer and why they continue to rise in popularity.

7. Sterile Formulation Development 7/1/2022

   With over 20 years of experience, PCI’s strength lies in our ability to manage products with unique challenges ranging from small molecules presenting with solubility issues or a labile molecule that is only stable as a liquid presentation for a short time.

8. Formulation Strategies For Poorly Soluble Molecules 3/3/2022

   As the number of poorly soluble compounds continues to increase in the industry development pipeline, conventional formulation strategies may not be sufficient to achieve acceptable levels of solubility in the gastrointestinal tract and hence absorption into the systemic circulation.

9. Pre-Formulation And Material Sciences 3/3/2022

   Our formulation development and material sciences experts have over 30 years’ experience in pre-formulation and solid state characterization.

10. cGMP Aseptic Manufacturing And Sterile Fill-Finish 1/28/2022

    Experienced CDMOs will implement a cGMP aseptic manufacturing and sterile fill-finish policy to improve drug bioavailability. Aseptic fill-finish is a process in which the drug product, container, and container closure are sterilized separately and then integrated. Combining the drug, container, and closure in a clean room using special equipment that is self-contained in a sterile environment meets FDA guidelines related to cGMP.